Connect with us

Politics

Where Canada’s Political Parties Stand On Marijuana And Drugs Ahead Of The Election

Published

on

Canadian voters will decide on Monday whether Prime Minister Justin Trudeau’s Liberal Party will retain control of the federal government, or if one of several competing parties will get a chance to take over.

The result of the election could have a variety of implications for marijuana policy about one year after the country legalized cannabis—a reform move that Trudeau campaigned on in 2015.

But it’s not just marijuana positions that separate the parties, as broader drug policy issues have also exposed differences in the direction Canada may take depending on which party controls the House of Commons.

Here’s a breakdown of where each party and their respective leaders stand on drug policy.

Liberal Party: Justin Trudeau

During his first campaign for prime minister, Trudeau pledged to legalize cannabis nationwide if elected—and while it didn’t materialize as quickly as he’d anticipated, marijuana prohibition was officially ended for adults in October 2018.

But while the prime minister scored points with advocates for making good on his promise, he’s disappointed others with the specifics of its implementation and for repeatedly declining to give his support to broader drug decriminalization efforts.

Trudeau was asked in February 2018 whether his administration would consider lifting criminal penalties for opioid possession as a means to combat the drug crisis. He responded that the policy is “not a step that Canada is looking at taking at this point.”

“It’s not part of the plan,” Trudeau, who admitted to using cannabis while serving in the House of Commons, said. “There are many steps we can and have taken.”

He made similar comments when he was asked about the same issue the previous year, stating that the country “is not looking at decriminalization or legalization of any other drugs other than what we’re doing with marijuana.”

The reasoning, Trudeau said, is because “there’s a lot of other tools that we are using right now instead.”

“We are going to focus on getting the control and regulation of [the] marijuana regime right, and that’s quite a handful right now,” he said. “We’re not looking at any other steps.”

Trudeau’s views on the issue don’t necessarily align with those of his party, however. Liberal delegates voted in favor of a resolution that sought to remove criminal penalties for drug offenses at a convention last year, hoping to put the policy on the party’s campaign platform for this upcoming election.

“The Government of Canada should treat drug abuse as a health issue, expand treatment and harm reduction services and re-classify low-level drug possession and consumption as administrative violations,” the measure stated.

Following the vote, however, Trudeau said at a press conference that “it’s not part of our plans.”

The party did ultimately adopt a formal platform backing certain harm reduction policies such as safe consumption sites and stipulating that first-time non-violent drug offenders should be diverted to drug treatment court in order to “help drug users get quick access to treatment, and to prevent more serious crimes.”

During a debate with Conservative Leader Andrew Scheer last month, decriminalization came up again. While Trudeau initially said it wasn’t on the party’s agenda “at the moment,” he later clarified in a press scrum that “we will not be further decriminalizing any drugs other than cannabis.”

Bill Blair, the parliamentary secretary to the minister of justice, said in April 2018 that the government had “no plans to legalize or decriminalize any other drugs” besides marijuana.

But despite opposition from the administration, some Liberal lawmakers have been undeterred. MP Nathaniel Erskine-Smith introduced a bill in July that would repeal sections of federal drug law that concern possession, effectively decriminalizing the controlled substances.

And the House of Commons Standing Committee on Health, which is controlled by the majority Liberals, issued a report in June recommending the government “work with provinces, territories, municipalities and Indigenous communities and law enforcement agencies to decriminalize the simple possession of small quantities of illicit substances.”

Conservative Party: Andrew Scheer

All but one member of the Conservative Party, including Scheer, voted against legalizing marijuana last year. However, if elected to the majority, Scheer said lawmakers wouldn’t seek to overturn the law.

“We will maintain…the fact that cannabis is legal, we are not going to change that and we do support the idea of people having those records pardoned” for prior cannabis offenses, he said in June.

While he’s pledged to uphold the legal marijuana program, the Conservative leader said during a debate with Trudeau that he’d use funds for cannabis tax revenue to increase enforcement against the illicit market. Scheer also accused the prime minister of promoting a “secret agenda” to decriminalize and legalize “hard drugs.”

The party also pushed advertisements on Facebook that falsely accused the Liberals of seeking to “legalize hard drugs.”

“This is yet another example of Conservatives copying the American right-wing playbook, spreading false information to scare and mislead voters,” Liberal Party spokesperson Joe Pickerill said in response to the ads.

Conservative Senators visited Washington, D.C. to meet with then-Attorney General Jeff Sessions in April 2018. The purpose of the trip, according to a press release, was to investigate the “predictable consequences of legalization for Canadians traveling to the United States” by discussing the matter with the anti-marijuana official.

Though Scheer and other Conservative lawmakers have derided drug policy proposals from the Liberals, their official party platform does stress the need to craft drug laws that treat addiction as a public health issue.

“To help more Canadians recover from addiction, we will revise the federal government’s substance abuse policy framework to make recovery its overarching goal,” the platform states. “We will reorient the Canadian Drugs and Substances Strategy towards ensuring that every addict has the opportunity to recover from their addiction and to lead a drug-free life and that all policies that fall under the Strategy have recovery as their objective.”

Conservatives also voiced support for expanding drug treatment facilities, funding education campaigns that encourage young people to avoid illicit substances and partnering with school districts and other institutions to clean up used needles.

New Democratic Party (NDP): Jagmeet Singh

All NDP lawmakers present for the vote on the cannabis legalization bill supported it. The party has not shied away from broader drug decriminalization, and members have emphasized the need to promote restorative justice in Canada’s marijuana program.

“New Democrats believe that there is much more we can do to save lives and support those struggling with opioids,” the party’s platform reads. “In government, we will declare a public health emergency and commit to working with all levels of government, experts and Canadians to end the criminalization and stigma of drug addiction, so that people struggling with addiction can get the help they need without fear of arrest, while getting tough on the real criminals—those who traffic in and profit from illegal drugs.”

The platform voiced support for expanding overdose prevention facilities and investigating the role of pharmaceutical companies in the opioid crisis and ensuring that the public is compensated if the industry is found culpable.

“We will also proactively expunge criminal records for Canadians convicted of minor cannabis possession,” NDP said. “With cannabis now legal in Canada, too many people are still burdened with criminal records for simple possession—records that mean real hardships that affect their employment opportunities and their ability to travel. These records for minor cannabis possession will be completely erased, allowing people to get on with building their lives.”

Singh has repeatedly proposed decriminalization as a solution to the country’s drug problems.

“I can tell you from personal experience, but I can also show you—and I’m sure you all know that there’s a preponderance of evidence when we look at those folks that are being charged with personal possession of a controlled substance people that are being arrested and incarcerated, these are folks that are struggling with issues of mental health of addiction and poverty,” Singh said in November 2017. “To me poverty, mental health and addictions don’t sound like criminal justice problems. They sound to me like a social justice problem that should be dealt with like a social justice problem.”

“That’s why I’m calling for the decriminalization of all personal possession offenses when it comes to drugs, to make a difference in the lives of people and actually bring real change,” he said.

During a debate as Singh was competing to become leader of NDP, he emphasized his decriminalization proposal.

“I would call for the immediate decriminalization of all personal possession offenses when it comes to drugs. Period,” he said.

NDP has also been critical of the rollout of Canada’s legal marijuana law, with the party writing in September that “Justin Trudeau’s Liberals had plenty of time to get this right” and it’s “not enough,” referring to the limited number of pardons for cannabis convictions that the government had issued.

“The NDP is going to keep fighting for criminal records for Canadians convicted of minor cannabis possession to be expunged,” they said.

NDP MP Don Davies unsuccessfully tried to get unanimous consent for a measure to “immediately provide pardons for those burdened by criminal records for cannabis offenses that will soon be legal” shortly after the legalization bill passed.

“For some people in Canada, and in some places, pot has been effectively legal for years,” Singh said in October 2018. “But depending on who you are, the color of your skin, and where you live, there’s a different set of rules.”

A private member bill introduced by NDP MP Murray Rankin to expunge criminal records for cannabis possession was rejected by Liberal lawmakers in May despite agreement that minority communities have been disproportionately impacted by federal drug laws.

In May, NDP urged their Liberal colleagues to answer questions about the impact of medical cannabis taxes on patients.

“The Liberal tax on medical cannabis is unfair and damaging to the health of patients. It shows that the Liberal government is out of touch with the reality of people,” NDP Deputy Leader Alexandre Boulerice said. “So far, my questions to the Minister have gone unanswered. But this time, I hope that he will finally justify the stance taken by the Liberals.”

“Medical cannabis must be treated just like other prescription drugs. Its price must be reviewed and untaxed in order to allow patients to treat themselves properly,” Boulerice said. “Some patients are forced to pay hundreds or thousands of dollars each month to get their medication. This is wrong!”

Green Party: Elizabeth May

May voted for the cannabis legalization bill, and the Green Party platform backs decriminalizing all drugs, pledging to “address the opioid crisis as a health-care issue, not a criminal issue, by declaring a national health emergency.”

“Drug possession should be decriminalized, ensuring people have access to a screened supply and the medical support they need to combat their addictions,” it says.

The platform includes several provisions aimed at reforming the current legal marijuana regime.

“A year into the legalization of cannabis, the flaws in the regulatory framework for cannabis production and sale are evident and a reform agenda is emerging,” the party said, adding that the government’s regulatory approach “treats the production of cannabis as uniquely dangerous” and that’s contributed to the ongoing presence of an illicit market.

To combat the issue, Green Party said it would lower the federally set price of marijuana to be more competitive with illicit sellers, eliminate “excess plastic packaging” requirements, remove excise duties and sales tax on medical cannabis products, allow outdoor cultivation, impose organic production standards and allow CBD to be marketed as a natural health supplement.

“Security requirements mean growers must use more energy and water and deal with diseases and pests that thrive in greenhouses, increasing costs and hobbling their ability to meet production expectations,” the platform says.

Other policies the party supports include expanding funding of community-based organizations that test drugs for safety and increase the availability of the overdose reversal medication naloxone.

“We must stop treating drug addiction as a criminal issue and start treating is as a health-care issue,” May said in a press release last month announcing her party’s support for decriminalization. “This is a national health emergency.”

“The opioid crisis is a national tragedy that is devastating communities and families across Canada,” she said. “We have to abandon old notions of the ‘war on drugs’ and join the battle that really matters—the fight to save Canadian lives.”

“It’s hard to stand up as a national party leader and say it’s time to decriminalize all illicit drugs,” May said during a press conference. “It’s what we have to do.”

“We have to take emergency steps in an emergency situation, and it’s far too dangerous to allow people, whether they’re living on the streets or living at home with their parents…to have illicit drugs that are not thoroughly screened for fentanyl contamination,” she said.

Bloc Québécois: Yves-François Blanchet

Members of the Bloc Québécois, which is primarily focused on advocating for Quebec sovereignty, voted against the marijuana legalization bill.

The party’s leader, Blanchet, doesn’t appear to have extensively discussed cannabis or drug policy issues.

Former Bloc Québécois Party Leader Martine Ouellet was more outspoken about the need for reform and said in 2017 that the country should nationalize a legal cannabis market.

“With the legalization…it creates a brand new market and [it] is a market that is currently occupied by criminal organizations,” she said. “The choice we have, do we want it to go from criminal organizations to private firms, big corporations, or if we want these profits to go from criminal organizations to all citizens?”

Ensuring that individuals provinces have the jurisdiction to allow or ban home cultivation for personal use was reportedly a key policy the party supported.

People’s Party of Canada (PPC): Maxime Bernier

Bernier, voted against the cannabis legalization bill as a Conservative lawmaker but said that he would not reverse it if elected. However, he pledged to remain watchful of the industry.

“In the longer term, my main worry is to make sure that we see the illegal market significantly reduced and ideally disappear,” he said through a spokesperson. “That was one of the key justifications for cannabis legalization.”

“If [the illicit market] stays large, we would look at regulatory and tax changes to ensure the legal market is better served,” he said. “We do not have any specific proposal for now. Same thing for edibles.”

According to Burnaby Now, Bernier has said that he’s in favor of marijuana legalization in principle and that the country should review the impact of safe consumption sites.

When running as for the leadership of the Conservative Party in 2016, Bernier welcomed an endorsement from Marc Emery, the so-called “Prince of Pot” who has since faced allegations of sexual misconduct. Emery said at the time, “I don’t even know what his position on marijuana is and I don’t care because for me Maxime Bernier represents a long-term future on all the issues” during a radio interview.

Days before Bernier formally launched the PPC last year, Emery told The Toronto Star that he “totally” endorses the candidate’s policies.

“I’ve never seen anything I disagree with,” Emery said.

Laura-Lynn Tyler Thompson, a PPC candidate, said earlier this year that the party does not have an official stance on cannabis policy but expressed personal opposition to legalization.

What To Expect

Analysts expect voter turnout to be down for the Liberals, as enthusiasm for Trudeau continues to suffer amid controversy over revelations that he wore blackface and brownface. That’s presented an opportunity that some of the lesser parties such as the Greens intend to take advantage of, with May urging voters to elect enough of her party members to the House of Commons to prevent the Liberals from winning an outright majority.

That situation would mean that “the Greens and other smaller parties would hold the balance of power, possibly even including the Bloc Québécois,” The New York Times reported.

But regardless of the outcome, what appears certain is that Canada’s legal marijuana law will survive no matter which party holds power, though the specifics of how the program will continue to roll out could depend on the electoral results.

A bigger question is whether the country will build on the momentum of cannabis legalization and pursue broader drug policy reforms such as decriminalization or if that movement will stall under unsupportive leadership.

Presidential Candidate Wants To Let Americans Legalize Marijuana Through National Referendum

Photo courtesy of Christopher Policarpio.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Politics

Massachusetts Lawmakers Discuss Drug Decriminalization And Safe Injection Sites At Hearing

Published

on

Massachusetts lawmakers on Monday heard testimony on separate proposals to decriminalize drug possession and establish a pilot program for safe injection facilities where people could use illicit substances in a medically supervised environment to prevent overdose deaths and facilitate treatment.

The state legislature’s Joint Committee on Mental Health, Substance Use and Recovery held a hearing on the harm reduction proposals, with experts and people personally impacted by substance misuse advocating for new approaches to drugs that destigmatize addiction and offer people resources outside of a criminal justice context.

The decriminalization bill would replace criminal penalties for the possession of any controlled substance with a civil fine of up to $50. To avoid the fine, individuals could enroll in a “needs screening to identify health and other service needs, including but not limited to services that may address any problematic substance use and mental health conditions, lack of employment, housing, or food, and any need for civil legal services.”

For the safe injection site legislation, the state would establish a 10-year pilot program where at least two facilities would “utilize harm reduction tools, including clinical monitoring of the consumption of pre-obtained controlled substances in the presence of trained staff, for the purpose of reducing the risks of disease transmission and preventing overdose deaths.”

A separate, less far-reaching bill that was added to the agenda in a late addition would direct the Department of Public Health to simply “evaluate the feasibility” of safe consumption sites and then report back to lawmakers by July 31, 2022..

The joint committee listened to academics, health professionals, lawmakers discuss the reform proposals but did not take immediate action on any of the legislation. It’s unclear when the bills will be taken up again for further consideration.

“By every metric, the war on drugs has been a catastrophic failure,” Rep. Mike Connolly (D) said. “In the United States and here in Massachusetts, the criminalization of drug possession is a major driver of mass incarceration. We know that black people have been incarcerated at a rate eight times higher than white people, and there’s no question that the criminalization of substance use issues has contributed to these terrible disparities.”

Connolly is also the sponsor of legislation that received a Joint Judiciary Committee hearing in July on  studying the implications of legalizing psychedelics like psilocybin and ayahuasca.

Officials with at least one Massachusetts city, Somerville, said that there are plans in the work to launch a safe injection facility in the jurisdiction. And they want to see the statewide bill pass to provide additional protections against being federally penalized.

“State legislation, wielding its constitutionally granted powers to enact laws for public health and safety, has the ability to greatly minimize these risks through legislation authorizing a pilot of safe consumption sites,” Hannah Pappenheim, assistant city solicitor at the City of Somerville, said. “In addition, state legislation would also minimize the risk of costly—but more importantly, lengthy—litigation.”

The official noted that a separate, Pennsylvania-based case on the legality of safe injection sites has been ongoing in federal courts for years at this point.

A coalition of 80 current and former prosecutors and law enforcement officials—including one who is President Joe Biden’s pick for U.S. attorney of Massachusetts—recently filed a brief urging the Supreme Court to take up the case.

Xavier Bacerra, the Biden administration’s secretary of health and human services, was among eight top state law enforcement officials who filed an earlier amicus brief in support of the Philadelphia-based Safehouse’s safe injection site plan when he served as California’s attorney general.

“State legislation paves the way for a more expedient process in Somerville, and of course elsewhere in the Commonwealth,” Pappenheim said.

Somerville Mayor Joseph Curtatone (D) said at Monday’s hearing that “it’s important for Massachusetts to finally lead—not just compiling, but implementing a strategy that reduces harm and save lives.” He conceded that he previously opposed the concept of allowing safe consumption sites; but his personal experience knowing people in his immediate family who suffered from addiction—as well as his own review of the scientific literature on harm reduction alternatives to criminalization—led him to embrace the reforms.

Massachusetts lawmakers advanced similar legislation last year, but it was not ultimately enacted.

The governor of neighboring Rhode Island signed a bill in July to establish a safe consumption site pilot program where people could test and use currently illicit drugs in a medically supervised environment. It became the first state in the country to legalize the harm reduction centers. It’s not clear whether the Department of Justice will seek to intervene to prevent the opening of such facilities in that state.

Oamshri Amarasingham, deputy legislative director of the ACLU of Massachusetts, voiced support for both reform proposals at Monday’s hearing and told WGBH that establishing a safe injection site pilot program “is one piece of that puzzle” that is “critically important and that’s had great success in other countries.”

Shaleen Title, a former Massachusetts cannabis commissioner who now heads the Parabola Center, juxtaposed how laws handle substances like caffeine, alcohol and nicotine differently from currently illegal drugs.

“What separates that from when we have these illicit drugs, where handcuffs and cages are involved, and what led that to be? The reason has nothing to do with science, or evidence or the relative dangers of those drugs,” she said. “The reason is because—and this is well-documented—those drugs could be scapegoated and blamed on their association with indigenous and Indian and Mexican and Chinese and other cultures, and then used to target communities of color, particularly black and Latino people nationally and here in Massachusetts.”

At the same time that Massachusetts legislators are looking into harm reduction and broad drug decriminalization, local activists in the state have also been pursuing psychedelics reform.

Three Massachusetts cities—NorthamptonSomerville and Cambridge—have each passed resolutions to deprioritize enforcement of laws against the possession, use and distribution of a wide range of psychedelics and other drugs. The Easthampton City Council is also exploring a resolution to decriminalize a wide range of entheogenic substances, with a meeting set for Friday.

Marijuana Arrests Dropped Sharply In 2020 As Both COVID And Legalization Spread, FBI Data Shows

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Marijuana Arrests Dropped Sharply In 2020 As Both COVID And Legalization Spread, FBI Data Shows

Published

on

Marijuana arrests declined significantly in 2020 amid the coronavirus pandemic, newly released FBI data shows.

There were 1,155,610 drug-related arrests overall last year, with cannabis sales and possession busts accounting for just over 30 percent (or 350,150) of those cases. The vast majority were for marijuana possession alone.

The agency’s data shows that there was a cannabis arrest every 90 seconds in the country in 2020, and there was a drug-related arrest every 27 seconds.

While these figures still highlight the rampant, ongoing criminalization of cannabis in states across the U.S., it’s a substantial deescalation compared to 2019, when FBI reported a total of 545,601 marijuana arrests. That amounted to a cannabis bust every 58 seconds.

Put another way, there was a 36 percent decrease in cannabis cases from 2019 to 2020. And while the federal agency doesn’t attempt to explain the statistical shift, there are a number of factors that could help explain it.

One of the more obvious societal changes during that timeframe is the COVID-19 health crisis, which involved social distancing requirements and generally discouraged people from being out in public where they might be at higher risk of being arrested for simple possession.

But advocates have also pointed out that the marijuana reform movement could be playing a role. Illinois’s adult-use cannabis law took effect at the beginning of 2020, for example. Hawaii, New Mexico and North Dakota also enacted decriminalization of marijuana possession in 2019, and Virginia followed suit the next year.

In Arizona, limited cannabis possession was legalized for adults starting on November 30, 2020 following voter approval of a reform initiative earlier that month.

“As more states move toward the sensible policy of legalizing and regulating cannabis, we are seeing a decline in the arrest of non-violent marijuana consumers nationwide,” NORML Executive Director Erik Altieri told Marijuana Moment. “The fight for legalization is a fight for justice. While these numbers represent a historic decline in arrests, even one person being put into handcuffs for the simple possession of marijuana is too many.”

Despite the decline in cannabis busts, the new data shows that American law enforcement still carried out more arrests for marijuana alone last year than for murder, rape, robbery, burglary, fraud and embezzlement combined.

It should be noted that not all local police participate in FBI’s reporting program, so these figures are not holistic and are estimates the agency makes based on those that do submit data.

The country had seen a consistent decline in cannabis arrests for roughly a decade prior to 2016, when those cases started to rise up until 2019.

Observers expect to see the downward trend in cannabis busts continue as more states move to end prohibition and law enforcement deprioritizes marijuana-relate cases. In New York, for example, police received new guidance this year stipulating that adults 21 and older can possess certain amounts of marijuana and consume it in places where tobacco use is permitted.

That directive alone seems to have led to a dramatic decrease in cannabis arrests in New York City.

Federal marijuana trafficking cases also continued to decline in 2020 as more states have moved to legalize, an analysis from the U.S. Sentencing Commission (USSC) that was released in June found.

Federal prosecutions of drug-related crimes overall increased in 2019, but cases involving marijuana dropped by more than a quarter, according to an end-of-year report released by Supreme Court Chief Justice John Roberts in December.

A study released by the Cato Institute in 2018 found that “state-level marijuana legalization has significantly undercut marijuana smuggling.

New York Governor Says Marijuana Legalization Will Create ‘Thousands’ Of Jobs And Touts Regulatory Appointments

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

New York Governor Says Marijuana Legalization Will Create ‘Thousands’ Of Jobs And Touts Regulatory Appointments

Published

on

The governor of New York says marijuana legalization will generate “thousands and thousands of jobs” in the state, and she’s touting her recent actions to make regulatory appointments for the industry to get implementation underway.

At the Business Council of New York State’s annual meeting on Friday, Gov. Kathy Hochul (D) talked about the state’s business ethic and the importance of supporting markets of all sizes, including cannabis companies.

“We do want to go big or go home, and I want to help you get there,” she said. “I need you to survive because you’re the identity of New York that people create jobs and opportunities. You are who we are as New Yorkers. Your success means the success of this entire state.”

“So count me in as an ally—someone who’s going to be there for you, who will fight for you to make sure that we do not lose out to any competition, whether it’s in the space of cannabis, where I believe there’s thousands and thousands of jobs and new industries, to be created that were not even focused on,” Hochul said.

The governor has made a point of emphasizing her support for adult-use legalization and standing up the industry since replacing former Gov. Andrew Cuomo (D), who resigned amid a sexual misconduct scandal last month.

At Friday’s meeting, she said, “I had to unleash this opportunity that had been stifled for the first five months [after legalization was signed into law] because a few appointments hadn’t been made. Got that done.”

Hochul named two additional Cannabis Control Board members last week, which followed the Senate confirmation of previous appointees earlier this month. The newly named regulators do not require confirmation by lawmakers.

According to The New York Post, the governor reportedly recently dismissed Norman Birenbaum, director of cannabis programs under Cuomo, whom advocates had opposed becoming the head of the new Office of Cannabis Management.

Under New York’s legalization law, the independent Office of Cannabis Management within the New York State Liquor Authority was established and will be responsible for regulating the recreational cannabis market as well as the existing medical marijuana and hemp programs. It will be overseen by a five-member Cannabis Control Board.

Three members have now been appointed by the governor, and the Senate and Assembly have also appointed one member each.

As it stands, adults 21 and older can possess up to three ounces of cannabis or 24 grams of concentrates in New York—and they can also smoke marijuana in public anywhere tobacco can be smoked—but there aren’t any shops open for business yet.

The first recreational marijuana retailers in New York may actually be located on Indian territory, with one tribe officially opening applications for prospective licensees earlier this month.

In July, a New York senator filed a bill to create a provisional marijuana licensing category so that farmers could begin cultivating and selling cannabis ahead of the formal rollout of the adult-use program. The bill has been referred to the Senate Rules Committee.

Because the implementation process has been drawn out, however, one GOP senator wants to give local jurisdictions another year to decide whether they will opt out of allowing marijuana businesses to operate in their area—a proposal that advocates say is unnecessary and would create undue complications for the industry.

Under the law as enacted, municipalities must determine whether they will opt out of permitting marijuana retailers or social consumption sites by December 31, 2021. Sen. George Borrello (R) introduced legislation earlier this month that would push that deadline back one year.

Legalization activists aren’t buying the argument, however.

Adding pressure to get the market up and running is the fact that regulators in neighboring New Jersey recently released rules for its adult-use marijuana program, which is being implemented after voters approved a legalization referendum last year.

The state comptroller recently projected that New York stands to eventually generate $245 million in annual marijuana revenue, which they say will help offset losses from declining tobacco sales.

For the first year of cannabis sales, the state is expected to see just $20 million in tax and fee collections. That will be part of an estimated $26.7 billion in new revenues that New York is expected to generate in fiscal year 2021-2022 under a budget that the legislature passed in April.

Meanwhile, a New York lawmaker introduced a bill in June that would require the state to establish an institute to research the therapeutic potential of psychedelics.

Florida Would Study Psychedelics’ Medical Benefits Under Top Senate Democrat’s New Bill

Photo courtesy of Mike Latimer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Marijuana Moment